Blood samples were obtained at baseline ( day 1 ) and on days 3 , 5 , and 7 , to assess total 25-hydroxyvitamin D , as well as vitamin D-binding protein and albumin to calculate bioavailable 25-hydroxyvitamin D. Plasma LL-37 and high-sensitivity C-reactive protein levels were also measured .